Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

2.

FLIP protein and TRAIL-induced apoptosis.

Roth W, Reed JC.

Vitam Horm. 2004;67:189-206. Review.

PMID:
15110178
3.

Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.

Aggarwal BB, Bhardwaj U, Takada Y.

Vitam Horm. 2004;67:453-83. Review.

PMID:
15110190
4.

TRAIL-induced signalling and apoptosis.

MacFarlane M.

Toxicol Lett. 2003 Apr 4;139(2-3):89-97. Review.

PMID:
12628743
5.

The complexity of TNF-related apoptosis-inducing ligand.

Abe K, Kurakin A, Mohseni-Maybodi M, Kay B, Khosravi-Far R.

Ann N Y Acad Sci. 2000;926:52-63. Review.

PMID:
11193041
6.

Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer.

Pennarun B, Meijer A, de Vries EG, Kleibeuker JH, Kruyt F, de Jong S.

Biochim Biophys Acta. 2010 Apr;1805(2):123-40. doi: 10.1016/j.bbcan.2009.11.004. Review.

PMID:
19961901
7.

Potential and caveats of TRAIL in cancer therapy.

Held J, Schulze-Osthoff K.

Drug Resist Updat. 2001 Aug;4(4):243-52. Review.

PMID:
11991679
8.

Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.

Whang YE, Yuan XJ, Liu Y, Majumder S, Lewis TD.

Vitam Horm. 2004;67:409-26. Review.

PMID:
15110188
9.

Death receptor ligands in tumors.

Cappello P, Novelli F, Forni G, Giovarelli M.

J Immunother. 2002 Jan-Feb;25(1):1-15. Review.

PMID:
11924906
10.

Apoptosis induced by death receptors.

Schneider P, Tschopp J.

Pharm Acta Helv. 2000 Mar;74(2-3):281-6. Review.

PMID:
10812970
11.

Regulation of lymphocyte proliferation and death by FLIP.

Thome M, Tschopp J.

Nat Rev Immunol. 2001 Oct;1(1):50-8. Review.

PMID:
11905814
12.

Targeting death-receptors in radiation therapy.

Niemöller O, Belka C.

Results Probl Cell Differ. 2009;49:219-39. doi: 10.1007/400_2009_17. Review.

PMID:
19582410
13.

c-FLIP, a master anti-apoptotic regulator.

Safa AR.

Exp Oncol. 2012 Oct;34(3):176-84. Review.

14.

Death receptor ligands, in particular TRAIL, to overcome drug resistance.

de Jong S, Timmer T, Heijenbrok FJ, de Vries EG.

Cancer Metastasis Rev. 2001;20(1-2):51-6. Review.

PMID:
11831647
15.

Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases.

Mitsiades N, Poulaki V, Mitsiades CS, Koutras DA, Chrousos GP.

Trends Endocrinol Metab. 2001 Nov;12(9):384-90. Review.

PMID:
11595539
16.

Targeting c-FLIP in cancer.

Shirley S, Micheau O.

Cancer Lett. 2013 May 28;332(2):141-50. doi: 10.1016/j.canlet.2010.10.009. Review.

PMID:
21071136
17.

The role of caspase-8 in resistance to cancer chemotherapy.

Kim PK, Mahidhara R, Seol DW.

Drug Resist Updat. 2001 Oct;4(5):293-6. Review.

PMID:
11991682
18.

Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer.

Bagnoli M, Canevari S, Mezzanzanica D.

Int J Biochem Cell Biol. 2010 Feb;42(2):210-3. doi: 10.1016/j.biocel.2009.11.015. Review.

PMID:
19932761
19.

TRAILing death in cancer.

Mellier G, Huang S, Shenoy K, Pervaiz S.

Mol Aspects Med. 2010 Feb;31(1):93-112. doi: 10.1016/j.mam.2009.12.002. Review.

PMID:
19995571
20.

The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis for cancer chemoprevention.

Szliszka E, Krol W.

Eur J Cancer Prev. 2011 Jan;20(1):63-9. doi: 10.1097/CEJ.0b013e32833ecc48. Review.

PMID:
20861738
Items per page

Supplemental Content

Support Center